| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| TILUDRONATE DISCONTINUED
| TILUDRONATE | MUSCULO-SKELETAL SYSTEM | ORAL | Cmax 9.4 MICROMOLAR (400 MILLIGRAM) F 6 PERCENT PPB 90 PERCENT HT 150 HOUR | TYROSINE-PROTEIN PHOSPHATASE | Matrix metalloproteinase-14 P50281 (MMP14_HUMAN) | ANSM (in French) | |||
